Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp Stock

39.53P/E
€4.14BMarket capitalisation
-US$0.45Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product,clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Adaptive Biotechnologies Corp is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Adaptive Biotechnologies Corp stock.

Market capitalisation
€4.14B
P/E
39.53
P/B
3.42
P/S
14.90
P/CF
-8.42
Issued shares 162M Units

Return

Here you can see the performance of the Adaptive Biotechnologies Corp stock.

PeriodPerfor­mance
1 Week+10.19 %
1 Month+5.74 %
3 Months-29.83 %
6 Months-64.91 %
1 Year-58.46 %
YTD-64.91 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Adaptive Biotechnologies Corp share.

DateRatio
27.11.20144:1

Which ETF contains the Adaptive Biotechnologies Corp stock?

The Adaptive Biotechnologies Corp stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Adaptive Biotechnologies Corp has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Adaptive Biotechnologies Corp stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.